BRIEF-J&J, AstraZeneca Explore COVID-19 Vaccine Modification In Response To Blood Clots - WSJ

AstraZeneca PLC:

* J&J, ASTRAZENECA EXPLORE COVID-19 VACCINE MODIFICATION IN RESPONSE TO RARE BLOOD CLOTS - WSJ

* J&J, ASTRA CONDUCTING EARLY-STAGE RESEARCH INTO WHETHER MODIFICATIONS OF THEIR COVID-19 VACCINES COULD REDUCE OR ELIMINATE RISK OF BLOOD CLOTS - WSJ

Also Read: BRIEF-AstraZeneca Plc Says Nirsevimab PhII/III Trial Confirms Safety Profile